← FDA DRUG APPROVALS

FDA ANDA · ANDA206798

DEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: ZYDUS PHARMS

APPLICATION
ANDA206798
TYPE
ANDA
ORIGINAL APPROVAL
2018-02-27
LATEST ACTION
2026-07-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

DEXMEDETOMIDINE HYDROCHLORIDEPrescription
DEXMEDETOMIDINE HYDROCHLORIDE EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) · INJECTABLE · INJECTION

Approval history

2026-07-08Labeling · Supplement 2 · standardAP
2026-07-08Labeling · Supplement 3 · standardAP
2018-02-27UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →